Effect of APP copy number variants in alzheimer's disease and and down syndrome on reelin expression and function

Ended Project Grant Awarded Last action

Award ID
R43AG084450
Recipient
Awarding agency
Obligated
$498,548

Award facts

Assistance listing
93.866 Aging Research
Completion date
Place of performance
California, USA

Award details come from USAspending.gov.

Description

Abstract
Chronic inflammatory pathology represents a major source of damage to the brain observed in down's syndrome (DS). Although the precise etiology of these diseases is often unknown, excessive leukocyte extravasation is a substantial contributor to the tissue damage/inflammation and our recent data show a prominent role of the plasma protein, reelin in this process. Furthermore, we have now shown that IT is possible, using anti-reelin monoclonal antibodies, to deplete the plasma of reelin, which results in a significant reduction of a wide range of vascular adhesion molecule expression. Thus, in contrast to the current methods of depleting individual adhesion molecules or immune receptors, our anti-reelin approach systematically downregulates all major inflammation-driven adhesion proteins on the vascular endothelium. The purpose of this proposal is to demonstrate the role of reelin in DS by 1) validating the therapeutic potential of mitigating chronic inflammatory milieu with an anti-reelin antibody in an DS mouse model and 2) identifying high affinity reelin antibodies for future therapeutic development.

Transactions

Action Obligated Date
Amendment $0
Amendment $238,549
Original award $259,999

Quick answers

Who received award R43AG084450?

R43AG084450 was awarded to Reelin Therapeutics, Inc. by National Institute on Aging (National Institutes of Health) on August 1, 2023.

How much is award R43AG084450 worth?

$498,548 has been obligated on R43AG084450.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award